|
Office Locations:
|
545 Middlefield Road, Suite 205
Menlo Park , CA 94025
Phone: 650-322-3475
| | |
|
|
|
|
Synergy Ventures seeks seed and early stage investment opportunities in U.S. medical device startups, with typical funding levels of $250K to $1M in its initial investment. The firm looks for start-up opportunities that can demonstrate clinical efficacy of their product or technology early on and create strong potential for partnership and acquisition. Synergy assists its portfolio companies in developing corporate partnerships in Japan at the appropriate time, which can provide significant strategic and economic benefits. The firm's sister company Synergy Partners International helps clients develop investment and strategic partnering relationships between U.S. medical technology companies and Japan corporations interested in expanding their medical business segments. Synergy's primary investment interests are in start-up companies developing medical device and diagnostic products that address major diseases and conditions prevalent in industrialized countries as the population ages (such as cancer, cardiovascular and neurological diseases, orthopedic problems, respiratory conditions, and gastrointestinal disorders). The firm has participated in over $1 billion in equity and other financial transactions for private U.S. medical technology companies.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|